kentucky semaglutide digestive blockage class action glp-1 gastric intestinal obstruction in lawyer gastrointestinal attorney West Virginia Wegovy Lawsuit semaglutide obstruction law – glp-1 gastric intestinal obstruction class – semaglutide gastrointestinal obstruction law office

The STEP clinical trials demonstrated mean weight losses of 14.9% to 17.4% in participants with overweight or obesity, with 69% to 79% achieving at least 10% weight loss

There is increasing recognition of the impact of obesity on workforce health (and as a result, on GDP), which further strengthens the case for healthcare systems investing more to enable additional widespread uptake of GLP-1RAs

Most importantly, the prebiotics are used to fortify and build up the intestinal lining, to prevent harmful bacteria from entering the bloodstream

Retatrutide availability claims should be treated cautiously unless they refer to legitimate clinical research or an approved product in a specific jurisdiction